Yahoo! Finance: Top Stories

Ascendis Pharma (ASND) Rated as a Hold at Cannacord Genuity on Growth Hormone Prospects

Jun 17, 2025 - 10:14
 0
Ascendis Pharma (ASND) Rated as a Hold at Cannacord Genuity on Growth Hormone Prospects
Read More

Tags:

Previous Article

IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners

Next Article

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety ...

Related Posts

These Stocks Are Moving the Most Today: Wolfspeed, UnitedHealth, Tesla, Nvidia, Target, Lowe’s, Alphabet, XPeng, VF Corp, and More

These Stocks Are Moving the Most Today: Wolfspeed, Unit...

May 21, 2025  0

RBC Reaffirms Outperform on Regeneron (REGN) Ahead of Key COPD Drug Results

RBC Reaffirms Outperform on Regeneron (REGN) Ahead of K...

May 30, 2025  0

UnitedHealth Stock Gains 8% After Insider Buys. New CEO Bought $25 Million.

UnitedHealth Stock Gains 8% After Insider Buys. New CEO...

May 21, 2025  0